EBV-positive low-grade follicular lymphoma transforming to EBV-negative high-grade B-cell lymphoma with MYC and BCL2 rearrangements

被引：1
作者：
Nam, Mann Hua [1 ]
Hsieh, Yao-Yu [2 ,3 ]
Chen, Bo-Jung [1 ]
机构：
[1] Taipei Med Univ, Shuang Ho Hosp, Dept Pathol, New Taipei, Taiwan
[2] Taipei Med Univ, Shuang Ho Hosp, Div Hematol & Oncol, New Taipei, Taiwan
[3] Taipei Med Univ, Sch Med, Div Hematol & Oncol, Dept Internal Med, Taipei, Taiwan
来源：
PATHOLOGY | 2022年 / 54卷 / 05期
关键词：
EPSTEIN-BARR-VIRUS;
D O I：
10.1016/j.pathol.2021.09.009
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：634 / 636
页数：4
相关论文
共 50 条
  • [1] Rituximab in the Treatment of EBV-positive Low Grade B-Cell Lymphoma
    Diamantopoulos, Panagiotis T.
    Polonyfi, Katerina
    Sofotasiou, Maria
    Papadopoulou, Vasiliki
    Kalala, Fani
    Iliakis, Theodoros
    Zervakis, Kostantinos
    Tsilimidos, Gerassimos
    Kouzis, Panagiotis
    Kyrtsonis, Marie-Christine
    Vassilakopoulos, Theodoros
    Angelopoulou, Maria
    Siakantaris, Marina
    Vayopoulos, George
    Kollia, Panagoula
    Pangalis, Gerassimos
    Viniou, Nora-Athina
    ANTICANCER RESEARCH, 2013, 33 (12) : 5693 - 5698
  • [2] EBV-positive follicular lymphoma and concurrent EBV-negative diffuse large B-cell lymphoma illustrating branched evolution model and "Hit and Run" hypothesis
    Kitagawa, Yukiko
    Peterson, Jess F.
    Kenney, Shannon
    Cheng, Liang
    Wang, Lin
    Dave, Sandeep
    Czader, Magdalena
    JOURNAL OF HEMATOPATHOLOGY, 2022, 15 (03) : 157 - 167
  • [3] EBV-positive follicular lymphoma and concurrent EBV-negative diffuse large B-cell lymphoma illustrating branched evolution model and “Hit and Run” hypothesis
    Yukiko Kitagawa
    Jess F. Peterson
    Shannon Kenney
    Liang Cheng
    Lin Wang
    Sandeep Dave
    Magdalena Czader
    Journal of Hematopathology, 2022, 15 : 157 - 167
  • [4] Spontaneous Regression of High-Grade B-Cell Lymphoma With MYC and BCL2 Rearrangements: Case Report and Literature Review
    Stanoszek, Lauren M.
    Smith, Lauren B.
    Grajewski, Karen
    Reneau, John C.
    Wilcox, Ryan
    Perry, Anamarija M.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (02) : E120 - E125
  • [5] Methotrexate-associated lymphoproliferative disorder demonstrating composite lymphoma of EBV-negative diffuse large B-cell lymphoma and EBV-positive mucocutaneous ulcer
    Moriya, Keiichi
    Kikuti, Yara Yukie
    Carreras, Joaquim
    Kondo, Yusuke
    Shiraiwa, Sawako
    Nakamura, Naoya
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2020, 60 (01) : 11 - 16
  • [6] Reappraisal of Epstein-Barr virus (EBV) in diffuse large B-cell lymphoma (DLBCL): comparative analysis between EBV-positive and EBV-negative DLBCL with EBV-positive bystander cells
    Ohashi, Akiko
    Kato, Seiichi
    Okamoto, Akinao
    Inaguma, Yoko
    Satou, Akira
    Tsuzuki, Toyonori
    Emi, Nobuhiko
    Okamoto, Masataka
    Nakamura, Shigeo
    HISTOPATHOLOGY, 2017, 71 (01) : 89 - 97
  • [7] EBV-positive diffuse large B-cell lymphoma of the elderly
    Ok, Chi Young
    Papathomas, Thomas G.
    Medeiros, L. Jeffrey
    Young, Ken H.
    BLOOD, 2013, 122 (03) : 328 - 340
  • [8] EBV-Positive Diffuse Large B-Cell Lymphoma in Young Immunocompetent Individuals
    Beltran, Brady E.
    Morales, Domingo
    Quinones, Pilar
    Medeiros, L. Jeffrey
    Miranda, Roberto N.
    Castillo, Jorge J.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2011, 11 (06) : 512 - 516
  • [9] EBV counteracts IL-21-induced apoptosis in an EBV-positive diffuse large B-cell lymphoma cell line
    Wu, Liang
    Ehlin-Henriksson, Barbro
    Zhu, Hong
    Ernberg, Ingemar
    Klein, George
    INTERNATIONAL JOURNAL OF CANCER, 2013, 133 (03) : 766 - 770
  • [10] EBV-positive diffuse large B-cell lymphoma of the elderly: A case series from Peru
    Beltran, Brady E.
    Castillo, Jorge J.
    Morales, Domingo
    Hurtado de Mendoza, Fernando
    Quinones, Pilar
    Miranda, Roberto N.
    Gallo, Aly
    Lopez-Ilasaca, Marco
    Butera, James N.
    Sotomayor, Eduardo M.
    AMERICAN JOURNAL OF HEMATOLOGY, 2011, 86 (08) : 663 - 667
12345